These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
435 related items for PubMed ID: 24238762
1. Radiologic assessment of earliest, best, and plateau response of gastrointestinal stromal tumors to neoadjuvant imatinib prior to successful surgical resection. Tirumani SH, Shinagare AB, Jagannathan JP, Krajewski KM, Ramaiya NH, Raut CP. Eur J Surg Oncol; 2014 Apr; 40(4):420-8. PubMed ID: 24238762 [Abstract] [Full Text] [Related]
2. ACRIN 6665/RTOG 0132 phase II trial of neoadjuvant imatinib mesylate for operable malignant gastrointestinal stromal tumor: monitoring with 18F-FDG PET and correlation with genotype and GLUT4 expression. Van den Abbeele AD, Gatsonis C, de Vries DJ, Melenevsky Y, Szot-Barnes A, Yap JT, Godwin AK, Rink L, Huang M, Blevins M, Sicks J, Eisenberg B, Siegel BA. J Nucl Med; 2012 Apr; 53(4):567-74. PubMed ID: 22381410 [Abstract] [Full Text] [Related]
3. Gastrointestinal stromal tumors: diagnosis and treatment. Acín-Gándara D, Pereira-Pérez F, Castaño-Pascual A, Durán-Poveda M, Antequera-Pérez A, Miliani-Molina C. Cir Cir; 2012 Apr; 80(1):44-51. PubMed ID: 22472152 [Abstract] [Full Text] [Related]
4. Management of gastrointestinal stromal tumors: looking beyond the knife. An update on the role of adjuvant and neoadjuvant imatinib therapy. Pandey R, Kochar R. J Gastrointest Cancer; 2012 Dec; 43(4):547-52. PubMed ID: 22847491 [Abstract] [Full Text] [Related]
5. Pathologic, radiologic and PET scan response of gastrointestinal stromal tumors after neoadjuvant treatment with imatinib mesylate. Goh BK, Chow PK, Chuah KL, Yap WM, Wong WK. Eur J Surg Oncol; 2006 Nov; 32(9):961-3. PubMed ID: 16842963 [Abstract] [Full Text] [Related]
6. Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor. Shen C, Chen H, Yin Y, Chen J, Zhang B, Chen Z, Chen J. Clinics (Sao Paulo); 2014 Nov; 69(11):758-62. PubMed ID: 25518034 [Abstract] [Full Text] [Related]
7. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Trent J, Patel SR, Raymond K, Feig BW. Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676 [Abstract] [Full Text] [Related]
8. Is there a role of surgery in patients with recurrent or metastatic gastrointestinal stromal tumours responding to imatinib: a prospective randomised trial in China. Du CY, Zhou Y, Song C, Wang YP, Jie ZG, He YL, Liang XB, Cao H, Yan ZS, Shi YQ. Eur J Cancer; 2014 Jul; 50(10):1772-1778. PubMed ID: 24768330 [Abstract] [Full Text] [Related]
9. Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib. Tielen R, Verhoef C, van Coevorden F, Gelderblom H, Sleijfer S, Hartgrink HH, Bonenkamp JJ, van der Graaf WT, de Wilt JH. Eur J Surg Oncol; 2013 Feb; 39(2):150-5. PubMed ID: 23084087 [Abstract] [Full Text] [Related]
14. The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST). Rutkowski P, Nyckowski P, Grzesiakowska U, Nowecki ZI, Nasierowska-Guttmejer A, Pienkowski A, Dudek K, Krawczyk M, Ruka W. Neoplasma; 2003 Feb; 50(6):438-42. PubMed ID: 14689066 [Abstract] [Full Text] [Related]
15. Neoadjuvant and adjuvant therapy with imatinib for locally advanced gastrointestinal stromal tumors in eastern Indian patients. Ashraf M, Jha J, Choudhry A, Aggarwal B, Nayak S, Chakraborty J, Majumder S, Biswas J. Asian Pac J Cancer Prev; 2011 Feb; 12(8):2059-64. PubMed ID: 22292651 [Abstract] [Full Text] [Related]
16. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib]. Banzo I, Quirce R, Martínez-Rodríguez I, Jiménez-Bonilla JF, Sainz-Esteban A, Barragán J, Portilla-Quattrociocchi H, Carril JM. Rev Esp Med Nucl; 2008 Feb; 27(3):168-75. PubMed ID: 18570858 [Abstract] [Full Text] [Related]